3654 results for «370»

Filter By

3654 results

Calcified left main lesion PCI

05 Jul 2019 – From AICT-AsiaPCR 2019

Consult this session to discover the key clinical data and angiographic reference of a patient presenting with calcified left main lesion PCI.

Calcified left main lesion PCI

Opening - LIVE demonstration from National University Heart Centre Singapore

04 Jul 2019 – From AICT-AsiaPCR 2019

Complex distal left main bifurcation lesion

04 Jul 2019 – From AICT-AsiaPCR 2019

A 75-year-old male with multiple risk factors and a history of NSTEMI is admitted for staged PCI to his left main bifurcation. His vessels are diffusely calcified…

Complex distal left main bifurcation lesion

AICT-AsiaPCR Opening Ceremony

04 Jul 2019 – From AICT-AsiaPCR 2019

Consult this session to watch AICT-AsiaPCR 2019 Opening Ceremony, led by Jean Fajadet. Discover the missions of PCR, and the novelties offered by the AICT-AsiaPCR course, arising from the Asia-Pacific region and showcasing its clinical research and innovations. 

AICT-AsiaPCR Opening Ceremony

How to choose material for a successful superficial femoral artery popliteal angioplasty?

22 May 2019 – From EuroPCR 2019

Consult this session to learn all about lesion specific strategies in complex superficial femoral artery obstructive disease, the impact of lesion length and calcification on treatment choice, and how to define treatment algorithm for drug coated balloons and stent devices.

How to choose material

Critical limb ischaemia antegrade below-the-knee angioplasty - LIVE Case

22 May 2019 – From EuroPCR 2019

Consult this session to learn all about first intention anterograde access, the currently available wires and how to use microcatheters and low-profile balloons.

Critical limb ischaemia antegrade below-the-knee angioplasty

Closing remarks - PCR Innovators Day 2019

20 May 2019 – From PCR Innovators Day 2019

Consult this session to discover the closing remarks on PCR Innovators Day 2019, regarding the presentations of innovative technologies: Cavis Technologies' WireCath, CorFlow Therapeutics, Procerion and GENOSS.

Closing remarks - PCR

How to optimise PCI in a patient with multivessel disease? LIVE Case

19 Dec 2019 – From GulfPCR-GIM 2019

Watch this case of an 81-year-old female with no prior history of CAD who presented with unstable angina. The patient had recent acute coronary syndrome and baseline angiography shows multivessel disease.

The objectives of this case are:

  1. Assess your patient as a whole package!
  2. Lesion preparation is key for...
How to optimise PCI in a patient with multivessel disease? LIVE Case

Management of mitral regurgitation patients undergoing TMVI screening

13 Jan 2022

This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.

Management of mitral regurgitation patients undergoing TMVI screening

PARTNER 3: weighing the comparative costs and savings of TAVI versus SAVR in low-risk patients with severe aortic stenosis

07 Nov 2021

Professor David J. Cohen presented the results of the economic outcomes of the PARTNER 3 trial on Friday, 5 November, in the Late-Breaking Trial session of the Transcatheter Cardiovascular Therapeutics Congress 2021. Giuseppe Biondi-Zoccai provides his analysis of this study.

Giuseppe Biondi Zoccai

Author

Giuseppe Biondi-Zoccai
PARTNER 3: weighing the comparative costs and savings of TAVI versus SAVR in low-risk patients with severe aortic stenosis

RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure

01 Sep 2024

Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.

The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...

Nicola Ryan

Author

Nicola Ryan
RESHAPE-HF2

3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications

22 Mar 2022

Ali Nazmi Calik provides his take on the long-term results of the SPYRAL HTN-ON MED trial which demonstrated the durable efficacy and safety of RDN in patients who are already on one to three antihypertensive drugs.

Ali Nazmi Calik

Author

Ali Nazmi Calik
3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications

The 2023 ESH Hypertension Guidelines revisit the role of renal denervation

05 Sep 2023

The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...

Lucas Lauder

Author

Lucas Lauder

Author

Felix Mahfoud
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation

Transfemoral TAVI in the horizontal aorta

12 May 2020

Real-world case report illustrating the benefits of the Portico with FlexNav TAVI system.

Transfemoral TAVI in the horizontal aorta
Didn’t find what you were looking for?